One year immunogenicity and safety of subunit plague vaccine in Chinese healthy adults: An extended open-label study

One year immunogenicity and safety of subunit plague vaccine in Chinese healthy adults: An extended open-label study

Background: To evaluate the one-year immunogenicity and safety of a subunit plague vaccine. Methods: In the initial study, 240 healthy adults aged 18–55 years were administrated with 2 doses of 15 or 30 µg plague vaccines at day 0 and 28, respectively. In this extended follow-up study, we evaluated...

Full description

Bibliographic Details
Main Authors: Jialei Hu, Lei Jiao, Yuemei Hu, Kai Chu, Jingxin Li, Fengcai Zhu, Taishun Li, Zhiyuan Wu, Dong Wei, Fanyue Meng, Bingxiang Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2018-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
plague vaccine
immunogenicity
safety
phase2a
vaccine clinical trial
Online Access:http://dx.doi.org/10.1080/21645515.2018.1486154

Internet

http://dx.doi.org/10.1080/21645515.2018.1486154

Similar Items